Levitee Labs Inc. (LVTTF)
Levitee Labs Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $369,155. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -662.4%. Its beta of 0.28 implies it has historically moved less than the broad market.
Levitee Labs Inc. is a holistic wellness enterprise dedicated to providing advanced, evidence-backed alternative treatments, including innovative psychedelic therapies. The company's operations are structured into two primary divisions: Medical Services and Product Sales. Through these, Levitee Labs delivers a range of treatments and medications addressing a broad spectrum of conditions such as substance addiction, various forms of chronic pain (including myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome), hepatitis-C, and mental health challenges. Its physical network encompasses five "Levitee Clinics" and three "Levitee Pharmacies," the latter operating specifically within Alberta. Additionally, Levitee Labs extends its reach by offering electronic prescription services for addiction treatment via its BlockMD platform and engaging in the wholesale distribution of supplements and superfoods under the Earth Circle Organics brand. Incorporated in 2019, the company, originally known as Fibonacci Capital Corp. until its rebranding as Levitee Labs Inc. on November 30, 2020, maintains its headquarters in Vancouver, Canada.
Levitee Labs Inc. is most often compared with the following Healthcare names: